Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
8.19
-0.04 (-0.55%)
At close: Jun 13, 2025, 4:00 PM
8.16
-0.02 (-0.26%)
After-hours: Jun 13, 2025, 4:23 PM EDT

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1,1051,2861,2916142,9661,750
Upgrade
Market Cap Growth
52.40%-0.41%110.30%-79.30%69.42%-20.79%
Upgrade
Enterprise Value
8701,0251,0472462,6881,367
Upgrade
Last Close Price
8.188.988.994.3222.8713.83
Upgrade
PE Ratio
30.75223.53----
Upgrade
Forward PE
13.0024.06----
Upgrade
PS Ratio
4.695.477.364.5865.0334.93
Upgrade
PB Ratio
3.223.413.421.516.194.29
Upgrade
P/TBV Ratio
3.193.453.461.546.304.39
Upgrade
P/FCF Ratio
17.2729.15----
Upgrade
P/OCF Ratio
17.1928.97----
Upgrade
EV/Sales Ratio
3.524.365.971.8458.9427.27
Upgrade
EV/EBITDA Ratio
14.0632.08----
Upgrade
EV/EBIT Ratio
20.5081.91----
Upgrade
EV/FCF Ratio
13.6023.25----
Upgrade
Debt / Equity Ratio
0.220.210.260.020.020.02
Upgrade
Debt / EBITDA Ratio
1.242.42----
Upgrade
Debt / FCF Ratio
1.221.80----
Upgrade
Asset Turnover
0.480.430.350.260.090.13
Upgrade
Inventory Turnover
1.161.241.982.303.14-
Upgrade
Quick Ratio
5.164.054.868.7611.8412.45
Upgrade
Current Ratio
5.934.575.509.6012.6313.11
Upgrade
Return on Equity (ROE)
11.23%1.52%-19.92%-24.46%-40.81%-29.07%
Upgrade
Return on Assets (ROA)
5.20%1.42%-10.53%-13.74%-22.43%-16.54%
Upgrade
Return on Capital (ROIC)
6.06%1.68%-12.06%-15.46%-24.99%-18.24%
Upgrade
Return on Capital Employed (ROCE)
9.70%2.80%----
Upgrade
Earnings Yield
3.61%0.45%-6.04%-17.62%-6.10%-5.87%
Upgrade
FCF Yield
5.79%3.43%-2.65%-13.00%-5.33%-4.32%
Upgrade
Buyback Yield / Dilution
-1.68%-2.07%-0.93%-9.70%-9.20%-27.36%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q